- Home
- CLLS vs MVBF Comparison
CLLS vs MVBF Comparison
Compare CLLS & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- MVBF
- Stock Information
- Founded
- CLLS 1999
- MVBF 1997
- Country
- CLLS France
- MVBF United States
- Employees
- CLLS N/A
- MVBF N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- MVBF Major Banks
- Sector
- CLLS Health Care
- MVBF Finance
- Exchange
- CLLS Nasdaq
- MVBF Nasdaq
- Market Cap
- CLLS 299.0M
- MVBF 282.7M
- IPO Year
- CLLS 2007
- MVBF N/A
- Fundamental
- Price
- CLLS $3.15
- MVBF $24.66
- Analyst Decision
- CLLS Buy
- MVBF Buy
- Analyst Count
- CLLS 1
- MVBF 4
- Target Price
- CLLS $4.00
- MVBF $24.50
- AVG Volume (30 Days)
- CLLS 76.4K
- MVBF 31.4K
- Earning Date
- CLLS 11-03-2025
- MVBF 10-29-2025
- Dividend Yield
- CLLS N/A
- MVBF 2.79%
- EPS Growth
- CLLS N/A
- MVBF N/A
- EPS
- CLLS N/A
- MVBF 1.29
- Revenue
- CLLS $63,438,000.00
- MVBF $143,378,000.00
- Revenue This Year
- CLLS N/A
- MVBF N/A
- Revenue Next Year
- CLLS $66.76
- MVBF $15.28
- P/E Ratio
- CLLS N/A
- MVBF $18.87
- Revenue Growth
- CLLS 223.09
- MVBF N/A
- 52 Week Low
- CLLS $1.10
- MVBF $15.59
- 52 Week High
- CLLS $3.35
- MVBF $25.13
- Technical
- Relative Strength Index (RSI)
- CLLS 54.47
- MVBF 64.85
- Support Level
- CLLS N/A
- MVBF $23.88
- Resistance Level
- CLLS $3.35
- MVBF $24.45
- Average True Range (ATR)
- CLLS 0.15
- MVBF 0.46
- MACD
- CLLS -0.09
- MVBF 0.03
- Stochastic Oscillator
- CLLS 94.03
- MVBF 100.00
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.